SmPC- Lamivudine Accord 300 mg Film-coated Tablets: Change history
View Summary of Product Characteristics (SmPC- Lamivudine Accord 300 mg Film-coated Tablets)
Last updated on this site: 11 Apr 2024
Description of update: Updates to SmPC sections 4.4 and 4.8 to align with the reference product (Epivir150 mg/ 300 mg film-coated tablets; EU procedure number: EU/1/96/015; MAH: ViiV Healthcare BV, Netherlands). The PIL has been updated accordingly including spelling and grammatical changes.
SmPC Sections updated: 4.4, 4.8 and 10.
View Summary of Product Characteristics (SmPC- Lamivudine Accord 300 mg Film-coated Tablets)
Last updated on this site: 11 Apr 2024
Description of update: Updates to SmPC sections 4.4 and 4.8 to align with the reference product (Epivir150 mg/ 300 mg film-coated tablets; EU procedure number: EU/1/96/015; MAH: ViiV Healthcare BV, Netherlands). The PIL has been updated accordingly including spelling and grammatical changes.
SmPC Sections updated: 4.4, 4.8 and 10.
-
Changes: (Updated: 11 Apr 2024)
Description of update: Updates to SmPC sections 4.4 and 4.8 to align with the reference product (Epivir150 mg/ 300 mg film-coated tablets; EU procedure number: EU/1/96/015; MAH: ViiV Healthcare BV, Netherlands). The PIL has been updated accordingly including spelling and grammatical changes.
SmPC Sections updated: 4.4, 4.8 and 10.
-
Changes: (Updated: 20 Sep 2022)
initial upload